Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FM3Q6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,532
Award facts
- Contract value 100% obligated
- $49,532.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $49,532.30 delivery order to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply relationships, specifically supporting DLA's medical supply chain requirements.
This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of medications, vaccines, medical devices, and healthcare commodities to military healthcare systems worldwide. The contract supports critical federal healthcare programs including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key pharmaceutical distributor for Department of Defense medical procurement across multiple therapeutic domains and global operations.
Quick answers
Who was awarded contract SPE2DR26FM3Q6?
SPE2DR26FM3Q6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FM3Q6 worth?
The government has obligated $49,532 on SPE2DR26FM3Q6.
Is contract SPE2DR26FM3Q6 an order under another contract?
Yes. SPE2DR26FM3Q6 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM3Q6 competed?
The extent of competition for SPE2DR26FM3Q6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award